Please turn JavaScript on
Find more feeds
Drug Development and Delivery icon

Drug Development and Delivery

Want to stay in touch with the latest updates from Drug Development and Delivery? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Drug Development & Delivery - The Latest Methods in Drug Development

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.31 / day

Message History

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Ne...
MONTREAL, CANADA – CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a Strategic Partnership with Sonic Healthcare USA, Inc. to launch the first commercial laboratory relationship in CellCarta’s Lab Network strategy, designed to support commercialization of companion diagnostic...

Read full story
Lonza Advances Integrated DNA to IND Programs Through Acceleration, De Risking, and Innovation

Basel, Switzerland, – Lonza, the world’s leading CDMO, announced today a strengthening of its biologics development services with an enhanced preclinical development offering designed to help customers make more confident early‑stage decisions while helping to accelerate timelines and...


Read full story
Deep Science Ventures and Medicines Discovery Catapult Partner to Accelerate Next Generation Brain Treatments

LONDON – 


Read full story
Microbot Medical Secures the First Healthcare System in North Carolina to Adopt the LIBERTY Endovascular Robotic System

HINGHAM, Mass., — Microbot Medical Inc., developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that it has secured its first North Carolina-based customer, becoming the latest healthcare system to adopt the LIBERTY System, demonstrating a broadening geographic penetration from the Southeast, Mid-Atlantic and Northeast U.S. The Company’s la...


Read full story
Spherix Data Reveals Explosive Demand for Wegovy Pill as $100B Weight Loss Race Intensifies

EXTON, PA, Spherix, the leading independent market intelligence and advisory firm for the global life sciences industry, announced new research highlighting how the race to dominate the $100 billion weight loss market is accelerating this quarter. Following the recent FDA approval of Wegovy (semaglutide), developed by Novo Nordisk, the first oral GLP-1 for we...


Read full story